Quest to Analyze One Thousand Humans Meditating
Public ClinicalTrials.gov record NCT06583395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects Of Meditation On The Gut Microbiome And Human Health and Disease
Study identification
- NCT ID
- NCT06583395
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Tobias Moeller-Bertram
- Industry
- Enrollment
- 3,000 participants
Conditions and interventions
Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Angina, Stable
- Anxiety
- Asthma
- Atrial Fibrillation
- Cancer Brain
- Cancer Colon
- Cancer Prostate
- Cancer Skin
- Cancer, Breast
- Cancer, Lung
- Cancer, Other
- Cancer, Ovarian
- Cancer, Thyroid
- Cerebral Palsy
- Chronic Fatigue Syndrome
- Chronic Kidney Diseases
- Chronic Obstructive Pulmonary Disease (COPD)
- Cluster Headache
- Crohn Disease
- Deafness
- Depression
- Diabetes
- Eczema
- Epilepsy
- Fibroids
- Fibromyalgia
- Heart Failure
- Hypertension
- Hyperthyroidism
- Hypothyroidism
- Infertility
- Irritable Bowel Syndrome (IBS)
- Lyme Disease
- Lymphoma
- Macular Degeneration
- Migraine
- Multiple Allergies
- Multiple Sclerosis
- Osteoarthritis
- Osteoporosis
- Ovarian Cysts
- Parkinson Disease
- Phantom Limb Pain
- Post Traumatic Stress Disorder (PTSD)
- Psoriasis
- Rheumatoid Arthritis
- Sjogrens Disease
- Spinal Cord Injury
- Spinal Stenosis
- Stroke
- Tension Headache
- Throat Cancer
- Tinnitus
- Ulcerative Colitis
Interventions
- Advanced multi-component meditation practice Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 4, 2021
- Primary completion
- Mar 24, 2025
- Completion
- Mar 24, 2025
- Last update posted
- Oct 31, 2024
2021 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VitaMed Research, LLC | Palm Desert | California | 92260 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06583395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06583395 live on ClinicalTrials.gov.